Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diphtheria toxoid + pertussis vaccine + tetanus toxoid + inactivated poliovirus vaccine (sabin strain)
- Development stage
- Unknown
- Lead developer
- Sanofi Pasteur
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
This is a **combination vaccine** used to provide active immunization against **diphtheria**, **tetanus**, **pertussis** (whooping cough), and **poliovirus**. It contains purified toxoids for diphtheria and tetanus, acellular components of pertussis, and inactivated poliovirus (Sabin strain), formulated to stimulate protective immune responses by inducing antibodies against these pathogens. It is primarily indicated for children as part of routine immunization schedules to prevent life-threatening and debilitating diseases. The mechanism of action involves exposing the immune system to non-pathogenic antigens that mimic infection, leading to memory immune cell development and long-term immunity[2][3][7].
- Brand names
- KinrixQuadracelAdacel-PolioBoostrix-Polio
- Other names
- DTaP-IPVTdap-IPV4-in-1 vaccine
02
Targets
Diphtheria toxin
Beyond the preview
Go deeper on diphtheria toxoid + pertussis vaccine + tetanus toxoid + inactivated poliovirus vaccine (sabin strain).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diphtheria toxoid + pertussis vaccine + tetanus toxoid + inactivated poliovirus vaccine (sabin strain).